Progen Pharmaceuticals Limited Improving cancer patients' lives
Progen Pharmaceuticals Limited (NASDAQ:PGLA; ASX:PGL) is a dual listed Australian company with operations in Australia and the US. Progen is committed to improving patient outcomes in the area of oncology, through the discovery and development of novel therapeutics.
Progen has built a focus and strength in anti-cancer drug discovery and development. Progen targets the multiple mechanisms of cancer across its three technology platforms, angiogenesis, cell proliferation and epigenetics.
Number of employees: 25
Main business focus/
Listing by sector:
|Contact person||Fleur Lankesheer|
|Job Title||Director of Legal and Business Development|
|Address||2806 Ipswich Road|
|Phone||61 7 3842 3333|
|Fax||61 7 3720 9624|